BTI
BBIO icon

Blue Trust Inc’s BridgeBio Pharma BBIO Stock Holding History

Blue Trust Inc’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5K Buy
155
+143
+1,192% +$10K ﹤0.01% 1827
2026
Q1 		$891 Buy
+12
New +$870 ﹤0.01% 2274
2025
Q2 		– Sell
-359
Closed -$12.4K – 2461
2025
Q1 		$12.4K Hold
359
– – ﹤0.01% 1804
2024
Q4 		$9.85K Buy
359
+174
+94% +$4.5K ﹤0.01% 1901
2024
Q3 		$4.69K Buy
185
+90
+95% +$2.36K ﹤0.01% 2419
2024
Q2 		$2.94K Buy
+95
New +$2.6K ﹤0.01% 2343
2024
Q1 		– Sell
-65
Closed -$2K – 2209
2023
Q4 		$2K Buy
+65
New +$1.95K ﹤0.01% 2099

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Blue Trust Inc's BBIO Position: Q2 2026 in Review

Blue Trust Inc increased its BridgeBio Pharma (BBIO) stake by 1,192% in Q2 2026, buying an estimated $10K and bringing the position to 155 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1827.

Blue Trust Inc first reported a position in BBIO in Q4 2023 and has held it in 7 quarters since. The position peaked at $12.4K in Q1 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Blue Trust Inc held 155 shares of BridgeBio Pharma worth $11.5K as of Q2 2026.
  • Blue Trust Inc bought 143 BridgeBio Pharma shares in Q2 2026, an estimated $10K.
  • BridgeBio Pharma made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1827 holding.
  • Blue Trust Inc first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 7 quarters since.
  • Blue Trust Inc's BridgeBio Pharma position peaked at $12.4K in Q1 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.